# FDA WARNING_LETTER - Bioiberica, SAU - February 04, 2022

Source: https://www.globalkeysolutions.net/records/warning_letter/bioiberica-sau/ec452cd4-ba0a-4296-a236-bbe9aa70c4fe

> FDA WARNING_LETTER for Bioiberica, SAU on February 04, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Bioiberica, SAU
- Inspection Date: 2022-02-04
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
- [Compliance Officer, CDER, Office of Manufacturing](https://www.globalkeysolutions.net/people/joseph-r-lambert/d2968fda-8e5e-433a-b60b-f68aaef3b7b0)

Company: https://www.globalkeysolutions.net/companies/bioiberica-sau/86731342-06fc-4b82-a0a9-9767dc0ccf4c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c